April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Retinal Vasoactive Effects Resulting From the Use of Topical Mydriatic Agents
Author Affiliations & Notes
  • C. Hudson
    School of Optometry, University of Waterloo, Waterloo, Ontario, Canada
    Dept of Ophthalmology and Vision Sciences,
    University of Toronto, Toronto, Ontario, Canada
  • E. Tsui
    Dept of Ophthalmology and Vision Sciences,
    University of Toronto, Toronto, Ontario, Canada
  • M. Sehi
    Ophthalmology, Bascom Palmer Eye Institute, U of Miami, Palm Beach Gardens, Florida
  • C. Wan
    School of Optometry, University of Waterloo, Waterloo, Ontario, Canada
  • S. Dorner
    Dept of Anesthesiology,
    University of Toronto, Toronto, Ontario, Canada
    Thornhill Research Inc, Toronto, Ontario, Canada
  • J. Fisher
    Dept of Anesthesiology,
    University of Toronto, Toronto, Ontario, Canada
    Thornhill Research Inc, Toronto, Ontario, Canada
  • Footnotes
    Commercial Relationships  C. Hudson, PCT/CA2005/001166, P; E. Tsui, None; M. Sehi, None; C. Wan, None; S. Dorner, Thornhill Research Inc, E; J. Fisher, PCT/CA2005/001166, P.
  • Footnotes
    Support  CIHR, CFI, Toronto Western Hospital Practice Plan
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 5041. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. Hudson, E. Tsui, M. Sehi, C. Wan, S. Dorner, J. Fisher; Retinal Vasoactive Effects Resulting From the Use of Topical Mydriatic Agents. Invest. Ophthalmol. Vis. Sci. 2010;51(13):5041.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To compare the vascular reactivity responses of the superior-temporal, and inferior-temporal, arterioles using 3 different mydriatic agents: 1% tropicamide (T); a combination of 0.8% tropicamide and 5% phenylephrine (TP); and 1% cyclopentolate (C).

Methods: : One randomly selected eye of each of 10 healthy volunteers (age 22.0±3.1, 6 females) was prospectively enrolled. Volunteers were examined at three visits. At visit 1, pupils were dilated using 1% tropicamide (T), at visit 2 using a combination of 0.8% tropicamide and 5% phenylephrine (TP) and at visit 3 using 1% cyclopentolate (C). At each visit, volunteers were connected to a sequential gas delivery circuit and an automated gas sequencer (RespirActTM, Thornhill Research Inc., Toronto, Canada) and underwent a gas provocation protocol consisting of 2 phases. Baseline was achieved with gas flow adjusted to provide a PETCO2 of 38mmHg. Hyperoxia was achieved at a PETO2 of 500mmHg with PETCO2 clamped at 38mmHg. Four flow measurements were acquired of the superior temporal (STA) and of the inferior temporal arterioles (ITA), using the Canon Laser Blood Flowmeter (CLBF-100, Canon, Japan), at equivalent positions during each phase. Repeated measures ANOVA using JMP software (v. 8.0, SAS Inc., Cary, NC) was performed.

Results: : The vascular reactivity in terms of the diameter, velocity and flow response was the same when comparing the STA and ITA using T, TP or C. The vascular reactivity responses of STA diameter (p=0.8; T=13.7µm ± 3.5, TP=12.2 ± 6.7, C=12.3 ± 5.6) and ITA diameter (p=0.5; T=15.0µm ± 9.6, TP=11.1 ± 7.4, C=11.7 ± 4.6) were the same for the three mydriatic agents (i.e. across the 3 visits). The vascular reactivity responses of STA velocity (p=0.9; T=9.8mm/sec ± 4.7, TP=9.9 ± 6.3, C=9.9 ± 4.7) and ITA velocity (p=0.7; T=10.3mm/sec ± 5.3, TP=10.3 ± 3.0, C=8.8 ± 4.4) were also the same for the three mydriatic agents. The vascular reactivity responses of STA flow (p=0.9; T=4.4 ± 1.6µL/min, TP=4.2 ± 1.7, C=4.3 ± 1.2) and ITA flow (p=0.3; T=6.1µL/min ± 3.8, TP=4.6 ± 1.2, C=4.7 ± 0.8) were the same for the three mydriatic agents.

Conclusions: : The three mydriatic agents investigated in this study do not affect the retinal vascular reactivity response of the major arterioles to hyperoxia.

Keywords: blood supply • metabolism • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×